greeksoup/ stock research
Stock research / United States / IFF · Industrial Organic Chemicals · NYSE

International Flavors & Fragrances Inc. (IFF)

IFF creates and manufactures products used in food, beverage, health and biosciences and scent, along with adjacent products including natural health ingredients. Its customers make dairy, meat, beverages, snacks, savoury and sweet foods, baked goods, personal care products, soaps and detergents, cleaning products, perfumes, dietary supplements, food protection, infant, elderly and animal nutrition, functional food, bio-fuel and oral care products. The United States was approximately 28% of sales in 2025, no other country was more than 10%, and no customer was 10% or more. In 2025 the business ran five segments, Taste, Food Ingredients, Health and Biosciences, Scent, and Pharma Solutions until that business was sold in May 2025; the former Nourish segment was split into Taste and Food Ingredients on 1 January 2025.

International Flavors & Fragrances Inc.

IFF creates and manufactures products used in food, beverage, health and biosciences and scent, along with adjacent products including natural health ingredients. Its customers make dairy, meat, beverages, snacks, savoury and sweet foods, baked goods, personal care products, soaps and detergents, cleaning products, perfumes, dietary supplements, food protection, infant, elderly and animal nutrition, functional food, bio-fuel and oral care products. The United States was approximately 28% of sales in 2025, no other country was more than 10%, and no customer was 10% or more. In 2025 the business ran five segments, Taste, Food Ingredients, Health and Biosciences, Scent, and Pharma Solutions until that business was sold in May 2025; the former Nourish segment was split into Taste and Food Ingredients on 1 January 2025.

Taste and Food Ingredients

Taste develops and produces flavour compounds and natural taste solutions used in savoury products such as soups, sauces, meat, fish, poultry and snacks, in beverages from juice drinks to spirits, in sweets including bakery, candy, cereal and chewing gum, and in dairy products, along with value-added spices and seasoning for meat, food service, convenience, alternative protein and culinary uses. Food Ingredients holds natural, artificial and plant-based specialty ingredients that give food and beverages their functional properties, plus specialty soy and pea protein with value-added formulations, emulsifiers and sweeteners. It also covers natural antioxidants and anti-microbials used to preserve beverages, cosmetics, healthcare products, pet food and feed additives and extend their shelf life, savoury solutions such as spices, marinades and mixtures, and inclusion products combining flavourings with fruit, vegetables and other natural ingredients.

Health and Biosciences

The segment produces enzymes, food cultures, probiotics and specialty ingredients for food and non-food use, and is made up of five businesses. Health supplies ingredients for dietary supplements, functional food and beverage, specialised nutrition and pharma. Food Biosciences supplies products for fresh dairy, cheese, bakery and brewing that extend shelf life and affect stability, taste and texture, with enzyme solutions that allow low sugar, high fibre and lactose-free dairy. Home and Personal Care makes enzymes for laundry and dishwashing detergents, cleaning and textiles, plus patented enzymatic polymers that are renewable and biodegradable alternatives to functional ingredients in home cleaning and beauty products. Animal Nutrition makes feed enzymes and animal health products for livestock farming, and Grain Processing makes yeasts and enzymes for biofuel production and carbohydrate processing.

Scent

The segment creates fragrance compounds and fragrance ingredients used in perfumes and in household and personal care products. Fragrance Compounds are proprietary combinations of several ingredients, organised into fine fragrances, covering perfumes and colognes from luxury to mass market, and consumer fragrances, covering fabric care such as laundry detergents and softeners, home care such as household cleaners, dishwashing detergents and air fresheners, and body care such as personal wash, hair care and toiletries. Fragrance Ingredients are natural and synthetic, active and functional ingredients used internally and also sold to third parties, including competitors, with spare manufacturing capacity used to make ingredients for outside sale while securing supply for the company's own perfumers.

What was sold

The former Pharma Solutions segment produced cellulosics and seaweed-based pharmaceutical excipients used in prescription and over-the-counter medicines and dietary supplements. That disposal group, including certain adjacent businesses, was sold on 1 May 2025, and the nitrocellulose business inside the segment was sold on 9 May 2025.

Materials, plants and people

At 31 December 2025 the company sourced approximately 20,000 different raw materials from a broad network of domestic and international suppliers and distributors. Natural ingredients come from flowers, fruits and other botanicals and from plant, animal and marine products and commodity crops such as wheat, corn and soy, bought direct from farms or in processed form, and combined with chemicals they also serve as raw materials for synthetic ingredients. Supply is managed through fixed or formula-based contracts, hedging materials linked to liquid commodities, strategic supplier relationships, indexed pricing, reduced formulation complexity, make-versus-buy decisions and local sourcing. There were approximately 170 manufacturing facilities, creative centres and application laboratories in approximately 30 countries, with major manufacturing sites in the United States, the Netherlands, Spain, Germany, Indonesia, Turkey, Brazil, Mexico, Slovenia, China, India, Ireland, Norway, Finland, Denmark, Belgium and Singapore. The company employed approximately 21,500 people worldwide at the same date, approximately 5,500 of them in the United States.

From International Flavors & Fragrances' annual report on Form 10-K for the year ended 31 December 2025. The filing

Compare with another name What $10,000 in International Flavors & Fragrances became

Latest results

Latest quarterQ3 FY2026ended 30 September 2026 · 10-Q filed 3 November 2026
Revenue
$1.9 billion
-27.9% on the year · -0.6% on the quarter
Q4 FY2024Q3 FY2026
Net income
-$55 million
Q4 FY2024Q3 FY2026
Diluted EPS
-$0.22
Q4 FY2024Q3 FY2026

this quarterthe same quarter a year earlierHover a bar for its figure.

Read the Q3 FY2026 results →the 10-Q on EDGAR ↗
Last full yearFY2025ended 31 December 2025 · 10-K filed 27 February 2026
Revenue
$10.9 billion
-5.2% on the year
FY2018FY2025
Net income
-$361 million
FY2018FY2025
Diluted EPS
-$1.41
FY2018FY2025

this yearthe year beforeHover a bar for its figure.

The years before, in wordsInternational Flavors & Fragrances (IFF) reported revenue of $10.9 billion for fiscal 2025, the year ended 31 December 2025, down 5.2% on the year before. Net loss was $361 million and the diluted loss per share $1.41. Revenue was $11.5 billion in fiscal 2024, $11.5 billion in fiscal 2023, $12.4 billion in fiscal 2022 and $11.7 billion in fiscal 2021. Net income in the same years was $263 million, a loss of $2.6 billion, a loss of $1.9 billion and $270 million. Over the twelve months to 30 September 2026, International Flavors & Fragrances reported revenue of $9.2 billion and net income of $182 million. Revenue grew 16.5% a year, compounded, over the five years to fiscal 2025. International Flavors & Fragrances declared $1.60 a share in dividends over the last four quarters and had 250 million shares outstanding at the latest filed count. At 30 September 2026 it carried $6.3 billion of debt and $272 million of cash. At the close of 6 November 2026 the market cap of International Flavors & Fragrances was $20.7 billion, 116.3 times its earnings over the last twelve months.
Read the FY2025 results →the 10-K on EDGAR ↗

Ratios

From the filings

ROE1.4%
ROCE3.5%
Operating margin7.5%
Net margin2.0%
FCF margin5.4%
Interest cover3.7x
Debt to equity0.47x
Cash conversion6.25x
Share count, last 12 months-2.3%
Sales CAGR, 3 years-4.3%
Profit CAGR, 3 yearsn/a
EPS, TTM$0.71

At the close of 6 November 2026

Price$82.61
Market cap$20.7 billion
Stock P/E116.3x
Price to book1.6x
EV / EBITDA18.0x
Dividend yield1.9%
Market cap / sales2.2x
52-week high$94.63
52-week low$62.00
Price, 1 year31.4%
Price CAGR, 3 years4.9%
Price CAGR, 5 years-10.5%

29 ready-made ratios, from FCF yield to net debt to EBITDA, wait on the Formulas page, each with what it tells you. Browse and add them →

Worked from the filed figures; hover a name for the formula.
Read moreThe priced ones use the latest price, the last regular-hours trade on IEX. Debt to equity here stands on long-term debt as International Flavors & Fragrances Inc. files it, with lease liabilities counted separately and never inside it. Nothing here is a valuation or a view.
IFFgreeksoup.ai
Daily prices to 6 November 2026, adjusted for splits; from 28 September 2026 each day's price is the last regular-hours trade on IEX.
Read moreData provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use. Day by day for the last three years; before that one point a week, carrying the week's last close and its average daily volume, so a volume bar means the same thing across the whole series; the bars sit under the price on their own scale, on the right. The moving averages need consecutive days and are drawn from the daily part. P/E is the close over the trailing four quarters' EPS as filed at each filing date, on the current share count; the dashed line is the median over the range shown. Sales and margin are quarterly revenue and the operating margin from the tables above. EV/EBITDA, price to book and market cap to sales use the latest filed balance sheet and share count at each date. Before the quarters on file begin, P/E, price to book and market cap to sales stand on each annual report from the day it was filed. Drawn in your browser; the range and overlay you pick are remembered here only.

Quarterly results

Q4 FY2021 *Q1 FY2022Q2 FY2022Q3 FY2022Q4 FY2022 *Q1 FY2023Q2 FY2023Q3 FY2023Q4 FY2023 *Q1 FY2024Q2 FY2024Q3 FY2024 †Q4 FY2024Q1 FY2025Q2 FY2025 †Q3 FY2025 †Q4 FY2025 *Q1 FY2026Q2 FY2026Q3 FY2026
Revenue3,0313,2263,3073,0632,8443,0272,9292,8202,7032,8992,8892,9252,7712,8432,7642,6942,5892,7411,9541,942
Cost of revenue2,0502,0812,1712,0621,9752,0631,9961,8961,8431,8751,8211,8731,7911,8081,7341,7111,6991,7231,1011,117
Gross profit9811,1451,1361,0018699649339248601,0241,0681,0529801,0351,0309838901,018853825
Gross margin32%35%34%33%31%32%32%33%32%35%37%36%35%36%37%36%34%37%44%42%
R&D166157158145143161161157157166173162170164182174174166170170
SG&A450459456413440454445444444490493495517461483421469427437387
Operating income173341213-1,985105131145150-2,536199191249127-90319822697.0273158160
Operating margin6%11%6%-65%4%4%5%5%-94%7%7%9%5%-32%7%8%4%10%8%8%
Interest expense73.072.077.083.010411111611043.083.079.074.069.071.061.048.049.044.046.046.0
Pre-tax income114285130-2,035-5.014.050.059.0-2,64111518395.0-115-99443813014.020964.0-134
Tax rate19%14%16%n/an/a157%46%54%n/a47%6%38%n/an/a-26%24%36%19%48%n/a
Net income90.0244107-2,197-25.0-9.027.025.0-2,61060.017058.0-46.0-1,01859940.018.016950.0-55.0
Net margin3%8%3%-72%-1%-0%1%1%-97%2%6%2%-2%-36%22%1%1%6%3%-3%
Diluted EPS$0.35$0.96$0.43-$8.60-$0.10-$0.04$0.11$0.10-$10.21$0.23$0.66$0.23-$0.17-$3.98$2.33$0.16$0.07$0.66$0.20-$0.22
Operating cash flow311-4.0-96.028920812724842064499.0237366368127241164318257422141
Capital expenditure15113210410816017511510011311882.010316017995.0132188165136148
Free cash flow160-136-20018148.0-48.0133320531-19.0155263208-52.014632.013092.0286-7.0
Buybacksn/an/an/an/an/an/an/an/an/an/an/an/an/a0.00.00.038.035.036.0513
Dividends paid201201201202206206207206207207102102103102102102103102102102
Shares outstanding255m255m255m255m255m255m255m255m255m255m256m256m256m256m256m256m256m255m255m250m
Filing10-K10-Q10-Q10-Q10-K10-Q10-Q10-Q10-K10-Q10-Q10-Q10-K10-Q10-Q10-Q10-K10-Q10-Q10-Q
Each quarter as filed, linked to its filing.
Read more* The fourth quarter is the full year less the first three quarters, because the company files the year and not the quarter on its own. A fourth quarter's EPS, and its diluted share count where shown, are from the company's results press release for that quarter, checked against the company's filed figures or a second data source. A quarter marked † is shown as the company last restated it in a later filing, so it compares with the quarters around it on one basis; rest on a figure for the one first filed. EPS is as filed. Money is in $ million as the company files it, or in $ billion by the switch above the tables; per share figures and the share count are as they are. Free cash flow is operating cash flow less capital expenditure; the effective tax rate is income tax over pre-tax income; margins are the line over revenue. Gross profit is revenue less cost of revenue, and operating income is revenue less the company's own total costs, where the statement does not print those lines. Cash flow lines filed year to date are the difference between two filings. Shares outstanding are at the period end where the balance sheet tags them, otherwise the count on the filing's cover page. A derived fourth-quarter EPS is left blank when a split in the year makes the arithmetic meaningless.

Income statement (profit and loss)

FY2008FY2009 †FY2010 †FY2011FY2012 †FY2013FY2014 †FY2015 †FY2016 †FY2017 †FY2018 †FY2019 †FY2020 †FY2021FY2022 †FY2023 †FY2024 †FY2025TTM
Revenue2,3892,3262,6232,7882,8212,9533,0893,0233,1163,3993,9785,1405,08411,65612,44011,47911,48410,8909,226
Cost of revenue1,4181,3921,5301,6831,6461,6691,7261,6721,7211,9262,2953,0272,9987,9218,2897,7987,3606,9525,640
Gross profit9719341,0931,1051,1761,2841,3621,3521,3961,4721,6832,1132,0863,7354,1513,6814,1243,9383,586
Gross margin40.6%40.2%41.7%39.6%41.7%43.5%44.1%44.7%44.8%43.3%42.3%41.1%41.0%32.0%33.4%32.1%35.9%36.2%38.9%
Research and development197185219220234260254246259295312346357629603636671694680
Selling, general and administrative4013914474444545065084955735707078769491,7491,7681,7871,9951,8341,720
Operating income284340416428487516592588553553584665566585-1,326-2,110766-382688
Operating margin11.9%14.6%15.9%15.3%17.2%17.5%19.2%19.5%17.7%16.3%14.7%12.9%11.1%5.0%-10.7%-18.4%6.7%-3.5%7.5%
Interest expense74.061.848.744.641.846.846.146.153.065.4133138132289336380305229185
Pre-tax income284277360374443485549539524537448557441354-1,625-2,518308-412153
Income tax54.381.096.010718913213512011924110897.274.075.023969.041.0-53.068.0
Effective tax rate19.1%29.3%26.7%28.6%42.7%27.1%24.5%22.2%22.7%44.9%24.1%17.4%16.8%21.2%n/an/a13.3%n/a44.4%
Net income230196264267254354415419405296340456363270-1,871-2,591263-361182
Net margin9.6%8.4%10.0%9.6%9.0%12.0%13.4%13.9%13.0%8.7%8.5%8.9%7.1%2.3%-15.0%-22.6%2.3%-3.3%2.0%
Diluted EPS$2.86$2.46$3.26$3.26$3.09$4.29$5.06$5.16$5.05$3.72$3.79$4.00$3.21$1.10-$7.32-$10.14$1.04-$1.41$0.71
Filing10-K10-K10-K10-K10-K10-K10-K10-K10-K10-K10-K10-K10-K10-K10-K10-K10-K10-K
From each year's 10-K, linked; TTM is the last four quarters.
Read moreFree cash flow is operating cash flow less capital expenditure; the effective tax rate is income tax over pre-tax income; margins are the line over revenue. Gross profit is revenue less cost of revenue, and operating income is revenue less the company's own total costs, where the statement does not print those lines. Those four are arithmetic on the filed numbers; everything else is as filed. Money is in $ million as the company files it, or in $ billion by the switch above the tables; per share figures and share counts are as they are. † The year as the company last restated it in a later filing; rest on a figure for the one first filed. EPS is as filed.

Revenue by segment FY2017 to FY2025

FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025Share
of the parts, latest year
Food Ingredientsn/an/an/an/an/an/a3,6923,3653,27830.1%
Tasten/an/an/an/an/an/a2,3032,4282,48122.8%
Scentn/an/a2,0332,0642,2542,3012,3932,4392,47922.8%
Health & Biosciencesn/an/a1291342,3292,3392,0712,2032,28321.0%
Pharma Solutionsn/an/a0.00.08099711,0201,0493693.4%
Flavors1,6322,092n/an/an/an/an/an/an/an/a
Fragrances1,7671,886n/an/an/an/an/an/an/an/a
Nourishn/an/a2,9782,8866,2646,829n/an/an/an/a
Food Ingredients FY2023 to FY2025Taste FY2023 to FY2025Scent FY2019 to FY2025Health & Biosciences FY2019 to FY2025Pharma Solutions FY2021 to FY2025Nourish FY2019 to FY2022Flavors FY2017 to FY2018Fragrances FY2017 to FY2018
3.4FY20175.1FY201911.7FY202111.5FY202310.9FY2025

$ billion; hover a block for its figure and share; a part named with years is one the company split its revenue into only then

From the company's 10-Ks, in its own words (latest 10-K).
Read moreEach year's figures come from the most recent 10-K that includes that year. A year is shown only where the parts add up to the revenue above. Fiscal years are labelled by the year they end in.

Profit by segment FY2019 to FY2025

The adjusted operating EBITDA each segment reports. Costs International Flavors & Fragrances does not charge to a segment are left out, so the segments can add up to more than the company's own adjusted operating EBITDA.

FY2019FY2020FY2021FY2022FY2023FY2024FY2025Margin
FY2025
Food Ingredientsn/an/an/an/a36940842312.9%
Tasten/an/an/an/a38946047819.3%
Scent42541646342349654551520.8%
Health & Biosciences334062563452457759426.0%
Pharma Solutions001652222022157620.6%
Nourish6585991,1721,176n/an/an/an/a
Food Ingredients FY2023 to FY2025Nourish FY2019 to FY2022Taste FY2023 to FY2025ScentHealth & BiosciencesPharma Solutions FY2021 to FY2025
1,116FY20191,055FY20202,425FY20212,455FY20221,980FY20232,205FY20242,086FY2025

$ million; the figure over a bar is all the segments together. Hover a block for its profit, sales and margin.

FY2025Share of salesShare of profit
Food Ingredients30%20%
Taste23%23%
Scent23%25%
Health & Biosciences21%28%
Pharma Solutions3%4%

Each column adds to 100%. A segment with a bigger share of the profit than of the sales makes more on each dollar it sells.

From the company's 10-Ks, in its own words (latest 10-K).
Read moreEach year's figures come from the most recent 10-K that includes that year. A year is shown only where every segment with sales that year has an adjusted operating EBITDA figure. A margin is a segment's adjusted operating EBITDA over its own sales.

Revenue by region FY2016 to FY2025

FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025Share
of the parts, latest year
EMEA9651,0661,3962,0821,9874,0934,2193,8343,8403,72734.2%
North America7699021,0101,1701,2283,4993,8533,4773,4403,19529.3%
Asian/a9049911,1631,1622,7282,8762,6772,7312,54623.4%
Latin America5025285807257071,3361,4921,4911,4731,42213.1%
Greater Asia880n/an/an/an/an/an/an/an/an/an/a
EMEANorth AmericaAsia FY2017 to FY2025Latin AmericaGreater Asia FY2016
3.4FY20175.1FY201911.7FY202111.5FY202310.9FY2025

$ billion; hover a block for its figure and share; a part named with years is one the company split its revenue into only then

From the company's 10-Ks, in its own words (latest 10-K).
Read moreEach year's figures come from the most recent 10-K that includes that year. A year is shown only where the parts add up to the revenue above. Fiscal years are labelled by the year they end in.

Cash flow

FY2008FY2009 †FY2010 †FY2011FY2012 †FY2013FY2014 †FY2015 †FY2016 †FY2017 †FY2018 †FY2019 †FY2020 †FY2021FY2022 †FY2023 †FY2024 †FY2025TTM
Operating cash flow2212923151893244085184675503914386997141,4373971,4551,0708501,138
Capital expenditure85.466.8106127126134143101126129170236192393504503463594637
Free cash flow13522520961.71982733753664242622674635221,044-107952607256501
Free cash flow margin5.7%9.7%8.0%2.2%7.0%9.3%12.1%12.1%13.6%7.7%6.7%9.0%10.3%9.0%-0.9%8.3%5.3%2.4%5.4%
Cash from investing-89.7-80.9-107-131-114-105-221-577-355-300-5,013-226-187-18.07455583262,269-431
Cash from financing-94.7-312-157-10125.4-217-202-165-34.4-42.64,871-505-512-1,304-1,229-1,851-1,606-3,091-809
Depreciation and amortisation76.078.579.275.376.783.289.489.61021181743233251,1561,1791,1421,015962793
Share-based compensation17.217.418.420.519.723.722.623.224.626.629.434.036.054.049.065.077.088.083.0
Buybacks30.02.0n/a0.00.051.488.212212758.115.50.00.0n/an/a0.00.038.0622
Dividends paid74.978.881.290.213187.3133159185206230314323667810826514409409
Dividend per sharen/a$1.00$1.04$1.16$1.30$1.46$1.72$2.06$2.40$2.66$2.84$2.96$3.04$3.12$3.20$3.24$1.60$1.60n/a
Diluted shares, weightedn/a79m80m81m82m82m81m81m80m79m88m113m114m243m255m255m256m256m253m
Shares outstanding at period endn/a79m80m81m82m81m81m80m79m79m107m107m107m255m255m255m256m256m250m
Filing10-K10-K10-K10-K10-K10-K10-K10-K10-K10-K10-K10-K10-K10-K10-K10-K10-K10-K
Cash paid in the year, from the cash flow statement.
Read moreThe dividend per share is as declared. Diluted shares are the weighted average for the year; a falling count is the buybacks net of issuance. TTM sums the last four quarters; the share counts are the latest quarter's.

Balance sheet

FY2008FY2009 †FY2010 †FY2011FY2012 †FY2013FY2014 †FY2015 †FY2016 †FY2017 †FY2018 †FY2019 †FY2020 †FY2021FY2022 †FY2023 †FY2024 †FY2025TTM
Funded by
Shareholders' equityn/a7699991,1041,2491,4631,5191,5901,6261,6846,0336,2176,31121,08217,68414,61113,83414,15413,259
Non-controlling interestn/a2.93.73.03.74.04.14.74.95.110.412.212.035.030.031.035.032.031.0
Redeemable equityn/an/an/an/an/an/an/an/an/a0.081.899.098.010559.00.0n/an/an/a
Debtn/a9359228951,0319339421,0681,3251,6444,5954,4174,44411,40010,97010,0718,9775,9946,273
Operating lease liabilitiesn/an/an/an/an/an/an/an/an/an/an/a253265670672642550533n/a
Finance lease liabilitiesn/an/an/an/an/an/an/an/an/an/an/a2.54.015.012.018.018.020.0n/a
Other liabilitiesn/a9389489639669321,0301,0391,0601,2652,1692,2862,4226,3516,0955,6055,2534,8065,262
Total liabilities and equityn/a2,6452,8722,9663,2503,3323,4953,7024,0174,59912,88913,28713,55639,65835,52230,97828,66725,53924,825
Owned
Fixed assetsn/a5015386086556877207337768811,2411,3871,4584,3684,2034,2403,7394,0292,648
Goodwilln/a6666666666666666759411,0001,1565,3785,4985,59316,41413,35510,6359,0808,2698,083
Intangible assetsn/a54.948.842.836.730.676.63063664163,0392,8522,72710,5069,0828,3576,4456,0433,470
Cash and equivalents17880.188.388.3324406479182324368635607650711483703469590272
Receivablesn/an/an/a47249952449453855166463.560.89291,9061,8181,7261,6241,7311,416
Inventoryn/a4455325445415345695725926491,0791,1231,1322,5163,1512,4772,1332,2451,452
Other assetsn/a8981,0005445284854814304094651,4541,7601,0663,2373,4302,8405,1772,6327,484
Total assetsn/a2,6452,8722,9663,2503,3323,4953,7024,0174,59912,88913,28713,55639,65835,52230,97828,66725,53924,825
Filing10-K10-K10-K10-K10-K10-K10-K10-K10-K10-K10-K10-K10-K10-K10-K10-K10-K10-K
At the fiscal year end; the TTM column is the latest quarter end.
Read moreBoth totals are the company's own. Other liabilities is the filed total less the rows above it: payables, deferred revenue, taxes, borrowings the rows above do not carry and the rest; other assets is the same on the other side. Investments add the current and non-current lines as filed. Debt is the company's own stated total where it files one, otherwise its long-term debt with the current maturities, never parts added together. A row is left blank in a year where the lines shown overlap and the remainder would fall below nil.

Compounded growth

10 years5 years3 yearsTTM
Sales growth, compounded13.7%16.5%-4.3%-16.7%
Profit growth, compoundedn/an/an/an/a
Return on equity, average3.3%-5.5%-6.1%-2.6%
Yearly growth, compounded; TTM is the last four quarters against the four before.
Read moreReturn on equity is net income over shareholders' equity at each year end, averaged over the window (the TTM column is the latest year alone); equity is the parent's shareholders' equity as tagged in the 10-K. Arithmetic on filed numbers, nothing forecast.

Questions

What was International Flavors & Fragrances' revenue in fiscal 2025?

International Flavors & Fragrances (IFF) reported revenue of $10.9 billion for fiscal 2025, the year ended 31 December 2025, down 5.2% on the year before.

How much did International Flavors & Fragrances earn in fiscal 2025?

Net loss was $361 million for fiscal 2025, and the diluted loss per share $1.41.

What is International Flavors & Fragrances' P/E ratio?

At the close of 6 November 2026, International Flavors & Fragrances traded at 116.3 times its earnings over the twelve months to 30 September 2026.

What is International Flavors & Fragrances' market cap?

The market cap of International Flavors & Fragrances was $20.7 billion at the close of 6 November 2026.

Does International Flavors & Fragrances pay a dividend?

Yes. International Flavors & Fragrances declared $1.60 a share in dividends over the four quarters to 30 September 2026.

Peers: Chemicals

CompanyMarket capP/EROEOp. marginSales growth
TTM		Debt to equityDiv. yield
International Flavors & Fragrances Inc. IFF$20.7 billion116.351.4%7.5%-16.7%0.471.9%
LyondellBasell Industries N.V. LYB$19.6 billion15.3411.6%8.6%-1.8%1.105.7%
Westlake Corp. WLK$8.1 billionn/a-5.2%-3.8%-0.4%0.583.3%
Newmarket Corp. NEU$6.4 billion14.0723.7%20.2%0.9%0.431.7%
Sensient Technologies Corp. SXT$5.1 billion30.0013.2%14.5%9.5%0.611.4%
REX American Resources Corp. REX$1.3 billion10.8017.9%n/a1.3%0.00n/a
Green Plains Inc. GPRE$933 million5.4020.7%10.7%-19.1%0.50n/a
Westlake Chemical Partners LP WLKP$751 millionn/an/a29.0%9.4%n/an/a
Gevo, Inc. GEVO$344 millionn/a-77.9%-102.8%121.4%0.61n/a
Alto Ingredients, Inc. ALTO$291 million5.8618.6%2.7%4.1%0.21n/a
FutureFuel Corp. FF$233 millionn/a-20.0%-20.8%-7.6%0.00n/a
Comstock Inc. LODE$148 millionn/a-35.6%-3,535.2%-52.2%0.08n/a
All 63 in Chemicals
CompanyMarket capP/EROEOp. marginSales growth
TTM		Debt to equityDiv. yield
Linde plc LIN$236.5 billion34.1817.8%25.3%8.2%0.681.2%
Air Products & Chemicals, Inc. APD$67.9 billionn/a-0.3%-4.7%4.5%1.272.4%
Nutrien Ltd. NTR *$34.5 billion15.349.0%13.9%3.5%0.423.1%
PPG Industries Inc. PPG$27.0 billion17.4918.5%n/a6.4%0.812.3%
Dow Inc. DOW$22.7 billionn/a-5.5%n/a4.2%1.096.7%
International Flavors & Fragrances Inc. IFF$20.7 billion116.351.4%7.5%-16.7%0.471.9%
LyondellBasell Industries N.V. LYB$19.6 billion15.3411.6%8.6%-1.8%1.105.7%
DuPont de Nemours, Inc. DD$19.4 billion65.742.2%n/a3.2%0.231.6%
CF Industries Holdings, Inc. CF$17.5 billion8.4338.1%41.6%17.9%0.561.8%
RPM International Inc. RPM$13.2 billion19.1419.8%n/a6.0%0.69n/a
Albemarle Corp. ALB$11.7 billion23.976.5%10.0%24.4%0.181.6%
Solstice Advanced Materials Inc. SOLS$9.1 billion28.4320.8%n/an/a1.48n/a
Westlake Corp. WLK$8.1 billionn/a-5.2%-3.8%-0.4%0.583.3%
Axalta Coating Systems Ltd. AXTA$7.8 billion23.5212.7%12.4%0.1%1.14n/a
Element Solutions Inc. ESI$7.6 billion36.887.1%11.7%39.6%0.721.0%
Eastman Chemical Co. EMN$7.4 billion11.4410.3%n/a0.3%0.835.2%
Mosaic Co. MOS$7.1 billionn/a-9.9%-5.1%0.0%0.563.9%
Newmarket Corp. NEU$6.4 billion14.0723.7%20.2%0.9%0.431.7%
Hexcel Corp. HXL$6.1 billion36.0412.9%12.2%7.6%0.710.9%
Balchem Corp. BCPC$5.5 billion32.8412.9%20.7%9.4%0.110.6%
Celanese Corp. CE$5.1 billion19.626.1%7.9%1.4%2.740.3%
Sensient Technologies Corp. SXT$5.1 billion30.0013.2%14.5%9.5%0.611.4%
Perimeter Group Inc. PRM$4.8 billion227.124.2%14.5%30.7%0.91n/a
CSW Industrials, Inc. CSW$4.4 billion34.9311.4%16.9%30.0%0.680.4%
Avient Corp. AVNT$4.2 billion23.347.3%9.7%5.2%0.742.4%
Scotts Miracle-Gro Co. SMG$3.8 billion56.26n/a11.8%-2.0%n/a4.1%
Cabot Corp. CBT$3.7 billion19.9611.8%13.6%-4.7%0.792.6%
WD-40 Co. WDFC$3.0 billion36.3530.2%15.8%11.0%0.321.8%
H.B. Fuller Co. FUL$2.7 billion13.909.1%n/a1.5%0.951.9%
Rogers Corp. ROG$2.2 billion48.213.7%7.9%6.7%0.00n/a
Ingevity Corp. NGVT$2.0 billion35.3194.9%n/a-6.5%18.18n/a
Olin Corp. OLN$2.0 billionn/a-13.1%-1.9%-0.7%1.754.6%
Innospec Inc. IOSP$1.9 billion13.7710.2%8.8%4.7%0.002.2%
Chemours Co. CC$1.9 billionn/a-99.4%0.6%0.1%24.732.7%
Minerals Technologies Inc. MTX$1.9 billionn/a-4.3%-1.6%4.8%0.610.8%
Huntsman Corp. HUN$1.6 billionn/a-6.5%0.0%6.5%0.773.7%
REX American Resources Corp. REX$1.3 billion10.8017.9%n/a1.3%0.00n/a
CVR Partners, LP UAN$1.2 billion10.88n/a20.6%7.3%n/an/a
Ecovyst Inc. ECVT$1.1 billion32.726.0%8.5%44.6%0.81n/a
Green Plains Inc. GPRE$933 million5.4020.7%10.7%-19.1%0.50n/a
Flotek Industries Inc. FTK$886 million30.5721.6%13.2%59.3%0.54n/a
FMC Corp. FMC$874 millionn/an/a-97.0%-22.0%n/a32.4%
Kronos Worldwide Inc. KRO$857 millionn/a-4.8%2.2%8.7%0.692.7%
LSB Industries, Inc. LXU$764 million17.108.2%11.2%13.0%0.79n/a
Westlake Chemical Partners LP WLKP$751 millionn/an/a29.0%9.4%n/an/a
Luxfer Holdings plc LXFR$463 millionn/an/an/an/a0.26n/a
Valhi Inc. VHI$456 million322.000.1%6.1%9.0%0.522.0%
AdvanSix Inc. ASIX$453 millionn/a-2.9%n/a8.4%0.343.8%
Tronox Holdings plc TROX$399 millionn/a-44.9%-5.1%12.0%2.858.0%
NLI Holdings, Inc. NL$351 millionn/a-1.3%9.8%4.3%0.005.4%
Gevo, Inc. GEVO$344 millionn/a-77.9%-102.8%121.4%0.61n/a
PureCycle Technologies, Inc. PCT$335 millionn/a-1,014.3%-1,313.8%141.7%7.93n/a
Alto Ingredients, Inc. ALTO$291 million5.8618.6%2.7%4.1%0.21n/a
ASP Isotopes Inc. ASPI$269 millionn/a-44.3%-321.1%573.4%0.99n/a
FutureFuel Corp. FF$233 millionn/a-20.0%-20.8%-7.6%0.00n/a
Orion S.A. OEC$224 millionn/a-8.1%4.0%0.9%2.482.0%
Lightbridge Corp. LTBR$163 millionn/a-11.7%n/an/a0.00n/a
Comstock Inc. LODE$148 millionn/a-35.6%-3,535.2%-52.2%0.08n/a
Ascent Industries Co. ACNT$124 millionn/a-1.2%-2.7%-6.1%0.010.0%
Aemetis, Inc. AMTX$120 millionn/an/a7.2%23.6%n/an/a
Arq, Inc. ARQ$112 millionn/a-28.7%-38.8%7.3%0.17n/a
Codexis, Inc. CDXS$101 millionn/a-93.2%-35.6%35.9%1.24n/a
Flexible Solutions International Inc. FSI$79 millionn/a-8.4%-2.6%-4.7%0.16n/a
13 companies share its SEC industry code (Industrial Organic Chemicals); the rest are the names nearest in size in its wider industry, Chemicals, one of the Fama-French 48 industries, a published grouping of SEC industry codes.
Read moreBy market capitalisation; a click on a heading sorts by it, largest first, and a second click turns it round. Each figure is the same arithmetic as the ratio box above, on each company's own filings and latest close; a name marked * is a foreign company that files once a year, on its latest fiscal year.

The public record on IFF

Dividends$1.60 a share over the four quarters to 30 September 2026, a 1.94% yield
Filings18 in twelve months: 9 current reports (8-K), about 4 results of operations; 2 other events; 2 material agreement; 1 officer or director change; 1 charter or bylaw amendment, or fiscal year change
Planned insider sales3 Form 144 notices in twelve months, $1.3 million; latest 17 August 2026
Options tapeput/call 0.67 by open interest at the 6 November 2026 close; the straddle prices a 5.1% move to 20 November 2026
13F holders759 funds reported a position for the quarter to 30 June 2026; largest Dodge & Cox
Insider trading9 sales and 13 purchases on Form 4 in twelve months
Congress0 House trades disclosed in six months
Short interest16.5 million shares short, 8.40 days to cover at 15 October 2026
Documentsthe 10-K, the 10-Qs, the proxy and 4 earnings press releases, each linked

Filings

FilingPeriodFiledWhere
10-Q30 September 20263 November 2026EDGAR
10-Q30 June 20264 August 2026EDGAR
10-Q31 March 20265 May 2026EDGAR
10-K31 December 202527 February 2026EDGAR
10-Q30 September 20254 November 2025EDGAR
10-Q30 June 20255 August 2025EDGAR
10-Q31 March 20256 May 2025EDGAR
10-K31 December 202428 February 2025EDGAR
10-Q30 September 20245 November 2024EDGAR
10-Q30 June 20246 August 2024EDGAR

Reading about a stock somewhere else? Our free Chrome extension, GreekSoup Stock Ticker Lookup: Earnings, Insider Trades, 13F Holders, shows the latest quarter against a year ago, insider trades and 13F holders when you hover a $ticker such as $AAPL.